Skip to content

Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis

Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04083482
Enrollment
20
Registered
2019-09-10
Start date
2018-08-20
Completion date
2019-12-31
Last updated
2019-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensive Care Unit

Keywords

Mitochondrial DNA, Sepsis, Continous venovenous hemofiltation, Intensive Care Unit

Brief summary

The plasma level of mtDNA in sepsis is affected by continous venovenous hemofiltation(CVVH)

Detailed description

Continous renal replacement therapy (CRRT)has become routine for patients with chronic renal failure ,AKI,fliud overload as well as oliguria in ICU .In clinical patients ,continous venovenous hemofoiltration (CVVH)is actually the method of chioce for CRRT in critically ill and hemodynamic instable patients .CVVH has significant beneficial effects on removing inflammatory cytokines ,improving oxygen index,increasing cardiac index and regulating immune dysfuntion .

Interventions

PROCEDUREcontinous venovenous hemofiltraion

CVVH

Sponsors

First People's Hospital of Chenzhou
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Adult septic patients undergoing CRRT

Exclusion criteria

1. Missing vists 2. transplatation 3. cancer 4. aquired immunodeficiency syndrome

Design outcomes

Primary

MeasureTime frameDescription
Change of mtDNA concentration in plasmabefor,6hours, 12hours, after CVVH treatmentThe specimens in the prefilter and postfilter blood as well as in the ultrafiltrate were obtained at the beginning of CRRT (T0) and 6 h (T6h), 12 h (T12h) after the setup of CVVH.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026